BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1255496)

  • 1. Stereospecific radioimmunoassay for propranolol isomers.
    Kawashima K; Levy A; Spector S
    J Pharmacol Exp Ther; 1976 Feb; 196(2):517-23. PubMed ID: 1255496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective antibodies to propranolol enantiomers produced from a new conjugate.
    Sahui-Gnassi A; Pham-Huy C; Galons H; Warnet JM; Claude JR; Duc HT
    Chirality; 1993; 5(6):448-54. PubMed ID: 8398604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of propranolol isomers and their relationships with beta adrenoceptor blocking activity in rabbits administered with dl-propranolol.
    Kawashima K; Ishikawa H
    J Pharmacol Exp Ther; 1980 Jun; 213(3):628-31. PubMed ID: 6110769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
    Nishimura T; Kita S; Abiko Y
    J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of d-methamphetamine in urine after administration of d- or dl-methamphetamine to rats by radioimmunoassay using optically sensitive antiserum.
    Niwaguchi T; Kanda Y; Kishi T; Inoue T
    J Forensic Sci; 1982 Jul; 27(3):592-7. PubMed ID: 7119715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-effect relationship of l-propranolol and metoprolol in spontaneous hypertensive rats after exercise-induced tachycardia.
    Brynne L; Karlsson MO; Paalzow LK
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1152-8. PubMed ID: 9732372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital.
    Chauvelot-Moachon L; Delers F; Poüs C; Engler R; Tallet F; Giroud JP
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1103-8. PubMed ID: 3252025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time required for complete recovery from chronic propranolol therapy.
    Faulkner SL; Hopkins JT; Boerth RC; Young JL; Jellett LV; Nies AS; Bender HW; Shand DG
    N Engl J Med; 1973 Sep; 289(12):607-9. PubMed ID: 4541874
    [No Abstract]   [Full Text] [Related]  

  • 10. A new radioimmunoassay for haloperidol: direct measurement of serum and striatal concentrations.
    Wurzburger RJ; Miller RL; Marcum EA; Colburn WA; Spector S
    J Pharmacol Exp Ther; 1981 Jun; 217(3):757-63. PubMed ID: 7230004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):295-301. PubMed ID: 6631714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of atropine in plasma.
    Wurzburger RJ; Miller RL; Boxenbaum HG; Spector S
    J Pharmacol Exp Ther; 1977 Nov; 203(2):435-41. PubMed ID: 909073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of propranolol isomers in mice.
    Levy A; Ngai SH; Finck AD; Kawashima K; Spector S
    Eur J Pharmacol; 1976 Nov; 40(1):93-100. PubMed ID: 991931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Propranolol beta-blocker decrease in the concentration of high-affinity binding sites for calcium ions by sarcolemma membranes of the rat heart].
    Seleznev IuM; Martynov AV; Smirnov VN
    Biull Eksp Biol Med; 1982 May; 93(5):72-4. PubMed ID: 7093513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecific and circadian-phase-dependent kinetic behavior of d,l-, l-, and d-propranolol in plasma, heart, and brain of light--dark-synchronized rats.
    Lemmer B; Bathe K
    J Cardiovasc Pharmacol; 1982; 4(4):635-44. PubMed ID: 6181339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereospecific antibodies to propranolol.
    Wang L; Chorev M; Feingers J; Levitzki A; Inbar M
    FEBS Lett; 1986 Apr; 199(2):173-8. PubMed ID: 3009217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific antibodies to methadone. I. Radioimmunoassay of d,l-methadone in human serum.
    Bartos F; Olsen GD; Leger RN; Bartos D
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):131-43. PubMed ID: 557222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF; Pichette V; du Souich P
    Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.
    Jaillon P; Hecklé J; Weissenburger J; Cheymol G
    J Pharmacol Exp Ther; 1980 Feb; 212(2):347-53. PubMed ID: 6101348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.